Results announcement for the second quarter 2014

GSK delivers Q2 2014 turnover £5.6 billion (-4%) and core EPS 19.1p (-12%) on ex-divestment basis (both CER). Q2 dividend 19p (+6%).

Source: GSK news - July 23, 2014 Category: Pharmaceuticals Source Type: news